Results 21 to 30 of about 25,638 (157)
Infectious Mononucleosis Hepatitis in Young Adults: Two Case Reports [PDF]
, 2009 Infectious mononucleosis due to Epstein-Barr virus (EBV) infection sometimes causes acute hepatitis, which is usually self-limiting with mildly elevated transaminases, but rarely with jaundice.
Adams +29 more
core +2 more sources
A new prediction diagnosis model of incomplete Kawasaki disease based on data mining with big data
Pediatric Discovery, EarlyView.In this study, based on a medical big data information mining approach, we mined the independent risk factors for incomplete Kawasaki disease prediction by comparing incomplete Kawasaki disease with related febrile illnesses and constructed an auxiliary diagnostic model used to predict incomplete Kawasaki disease.
Zhen Yang +4 more
wiley +1 more source
Hemolytic uremic syndrome linked to infectious mononucleosis [PDF]
, 2018 A 12-month-old boy developed a mild hemolytic uremic syndrome with no acute diarrheal prodrome. The typical clinical, hematological, and serological features of infectious mononucleosis were also noted.
Bianchetti, Mario +4 more
core
Expression of Epstein–Barr Virus–Encoded Small RNA (by the EBER-1 Gene) in Liver Specimens from Transplant Recipients with Post-Transplantation Lymphoproliferative Disease [PDF]
, 1992 Epstein-Barr virus (EBV)—associated post-transplantation lymphoproliferative disease (PTLD) develops in 1 to 10 percent of transplant recipients, in whom it can be treated by a reduction in the level of immunosuppression.
Anthony J. Demetris +26 more
core +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, is approved in Japan for adults with plaque, generalized pustular, and erythrodermic psoriasis who have inadequate response to conventional systemic therapies. In the Phase 3, open‐label POETYK PSO‐4 (NCT03924427) trial, deucravacitinib was efficacious and well ...
Yukari Okubo +10 more
wiley +1 more source
Allergy, EarlyView.Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller +13 more
wiley +1 more source
Airway compromise in infectious mononucleosis: a case report [PDF]
, 2009 A 25-year-old Caucasian man had difficulty swallowing and shortness of breath during an episode of infectious mononucleosis. His tonsils were “kissing” and erythematous but no superimposed infection with a streptococcal organism was identified.
Kakani, Sravan
core +2 more sources
Cold Urticaria and Infectious Mononucleosis in Children [PDF]
, 2004 Physical urticaria includes a heterogeneous group of disorders characterized by the development of urticarial lesions and/or angioedema after exposure to certain physical stimuli.
Arêde, C +5 more
core +1 more source
Advancements in multiple sclerosis
Internal Medicine Journal, EarlyView.Abstract The global prevalence of multiple sclerosis (MS) is increasing, and early diagnosis and treatment is essential in mitigating disability. While recent therapeutic advancements have significantly reduced relapse rates, the progressive and degenerative aspects of MS continue to pose major challenges.
Turlough Montague +3 more
wiley +1 more source
Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. [PDF]
, 1994 PTLD may be considered as an "opportunistic cancer" in which the immunodeficiency state of the host plays a key role in fostering the environment necessary for abnormal lymphoproliferation.
Nalesnik, MA, Starzl, TE
core